Normal Values of High Frequency ECG (HyperQ™) in Apparently Healthy Individuals and in Young and Masters Athletes
1 other identifier
observational
300
1 country
1
Brief Summary
The main objective of this study is to investigate depolarization characteristics represented by changes in HyperQ in asymptomatic, apparently healthy athletic and non-athletic individuals. We also aim to examine a subgroup of obese and non-obese subjects. The goal of the study is to establish normal HyperQ values in these populations and compare HyperQ values of age-matched athletic vs. non-athletic individuals of similar health status.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Feb 2009
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2009
CompletedFirst Submitted
Initial submission to the registry
February 18, 2009
CompletedFirst Posted
Study publicly available on registry
February 19, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2010
CompletedFebruary 4, 2010
February 1, 2010
1 year
February 18, 2009
February 3, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Normal values for depolarization characteristics will be established for study groups
end of data collection
Eligibility Criteria
community sample referred or self referred to stress testing
You may qualify if:
- An asymptomatic, apparently healthy patient performing a maximal exercise stress test
You may not qualify if:
- Contraindications for an exercise test
- Wolff-Parkinson-White (pre-excitation) syndrome
- Atrial Fibrillation or significant ventricular arrhythmia
- Treatment with Digoxin
- Pacemaker
- Pregnancy or suspected pregnancy
- QRS duration\>120ms or other conduction delays
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Ribstein Center for Sports Medicine and Research
Netanya, Israel
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Central Study Contacts
Study Design
- Study Type
- observational
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
Study Record Dates
First Submitted
February 18, 2009
First Posted
February 19, 2009
Study Start
February 1, 2009
Primary Completion
February 1, 2010
Study Completion
June 1, 2010
Last Updated
February 4, 2010
Record last verified: 2010-02